Biomedical subjects

G A Anderson

Publications and source records attributed to G A Anderson.

At least 91 records · Page 5Linked to original sources

PubMed1992

Ultrasound speed in the metacarpal cortex--a survey of 347 thoroughbreds in training.

Transmission ultrasound speed was determined in the third metacarpal bone of 347 Thoroughbred racehorses in training. In addition to direct measurement of apparent ultrasound speed and lateral bone diameter, several derived parameters were estimated (cortical ultrasound speed, corticomedullary ratio and cortical cross-sectional area). Multiple regression equations were developed for each ultrasound measurement using the explanatory variables: sex, age, duration and intensity of training, preparation number and previous shin soreness. The horses (114 females, 82 entire males and 151 geldings ranging in age from 20 to 116 months) had been in continuous training for an average of 10.0 weeks when measurements were made. All measurements except corticomedullary ratio were influenced by the sex of the horse. Geldings had significantly lower ultrasound transmission speed than entire males and females, reflecting a lower bone density. However, the geldings had larger cross-sectional areas (ie bone size). We suggest that the relationship between low ultrasound speed (ie low bone density) and large cross-sectional area maintains the overall mechanical integrity of the metacarpus. This relationship (high ultrasound speed and low cross-sectional area) was also found in each sex group. Ultrasound speed and corticomedullary ratio, but not cross-sectional area, were affected by age. Both duration and intensity of training influenced the ultrasound speed measurements. This study indicated that sex, age and state of training affect ultrasound results, but this explained only about 30% of the variance in the data. Other factors, ie genetic variation in bone density and size, differences in soft tissue thickness and distal limb temperature, presumably account for most of the variance.

Age Factors↗

PubMed1992

Antibody response of calves to immunoaffinity-purified bovine respiratory syncytial virus VP70 after vaccination and challenge exposure.

Immunoaffinity-purified bovine respiratory syncytial virus (BRSV) fusion (F) protein elicited anti-BRSV-specific antibody responses in BRSV-seronegative calves. After primary vaccination, all calves seroconverted to BRSV as determined by the virus neutralization (VN) test and developed anti-F protein antibodies detectable by protein immunoblot analyses. Subsequent vaccinations induced greater than twofold increase in VN titer in 3 of 9 (33%) calves, and 1 calf became VN-negative, but still had nonneutralizing antibody detectable by protein immunoblot analysis. This calf remained seronegative after challenge exposure. Two groups of calves were vaccinated IM with immunoaffinity-purified BRSV F protein. Each dose was 2 ml containing 20 micrograms of purified F protein. Freund's adjuvants were used for all vaccinations, with Freund's complete adjuvant used for the primary vaccination and Freund's incomplete adjuvant for subsequent vaccinations. The vaccine was administered to both groups at weeks 0 and 3; the first group received a third vaccination at weeks 21. Group-1 and -2 vaccinated calves and non-vaccinated contact controls were intranasally aerosol challenge-exposed with low cell culture-passage BRSV on weeks 22 and 9, respectively. Eight of 9 vaccinated calves did not develop a humoral anamnestic response following challenge exposure, as demonstrated by VN test and protein immunoblot analyses. Calf 14 from group 1 which had a 1:2 VN antibody titer prior to vaccination, was the only calf that developed an anamnestic response.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

PubMed1991

Extensor indicis proprius opponensplasty.

An analysis of 39 patients (40 hands) who underwent an extensor indicis proprius opponensplasty was carried out. Of these, 29 hands had simultaneous adjuvant surgery to correct other deformities. The mean follow-up period was 33.8 months. Excellent or good results were seen in 87.5%, fair in 10% and poor in 2.4% hands.

Adolescent↗

PubMed1991

Monoclonal antibodies to the fusion protein of bovine respiratory syncytial virus.

Five monoclonal antibodies specific for bovine respiratory syncytial virus were characterized by Western immunoblotting, radioimmunoprecipitation, and epitope mapping assays. The monoclonal antibodies were found to be specific for the fusion protein, and there were at least two antigen binding sites, one of which was neutralizing.

Animals↗

PubMed1991

In vitro and in vivo evaluation of effects of a heptanoyl tripeptide, FK-565, on porcine macrophage and lymphocyte function.

A series of experiments was performed in vitro and in vivo to determine the influence of FK-565, a heptanoyl tripeptide, on lymphocyte and macrophage function in swine. Compared with values for control cultures, mitogen-stimulated lymphocyte blastogenesis and interleukin-2 production were unaffected in cells preincubated with 0.1, 1.0, and 10.0 micrograms of FK-565/ml. Natural killer cell activity was increased by preincubation with 1.0 microgram of FK-565/ml; however, this increase was not statistically significant. In vitro treatment of porcine alveolar macrophages with FK-565 did not enhance cytolytic activity or bactericidal activity. In in vivo experiments, FK-565 given orally to pigs at concentrations of 6 or 60 micrograms.kg-1.d-1 for 5 days did not affect lymphocyte blastogenesis, interleukin-2 production, or alveolar macrophage bactericidal activity. A trend toward increased natural killer cell activity was evident in pigs treated with FK-565. In contrast, pigs treated with 6 micrograms.kg-1.d-1 had significantly (P less than 0.01) decreased alveolar macrophage cytolytic activity. These data indicate that at the dosages tested, FK-565 is not a suitable immunomodulator for enhancement of nonspecific immunity in swine.

Animals↗

PubMed1990

Resistance to host immune defense mechanisms afforded by capsular material of Pasteurella haemolytica, serotype 1.

Selected serum-mediated host immune defense mechanisms against Pasteurella haemolytica were studied using encapsulated and decapsulated organisms. When the capsular material was removed from P. haemolytica, it became more susceptible to serum agglutination, complement-mediated serum killing, and phagocytosis by polymorphonuclear leukocytes. When encapsulated organisms were used, phagocytosis was enhanced by antibodies to capsular material produced by vaccination of calves with any of three P. haemolytica vaccines. The serum bactericidal activity, however, was not facilitated by increased levels of anticapsular antibody in vaccinated cattle. By contrast, when decapsulated organisms were used, vaccination enhanced both the bactericidal and opsonizing capacities of sera from the calves. These studies indicate that capsular material should be considered a principal virulence factor for P. haemolytica.

Agglutination Tests↗

PubMed1990

Failure of an intramuscular injection of an analogue of gonadotrophin-releasing hormone 11 to 13 days after insemination to increase pregnancy rates in dairy cattle.

At 11 to 13 d after insemination, 1028 dairy cows on 19 farms were given an intramuscular injection of 10 micrograms of the GnRH analogue buserelin. Their reproductive performance was compared to 1022 control cows receiving a placebo. The GnRH analogue-treated cows had fewer short interoestrous intervals compared to the control cows, but there were no significant differences in pregnancy rates to either the insemination preceding or following treatment, in calving to conception interval, or to percent pregnant by the end of mating. There were no differences between treatments in herds of high, average or low pregnancy rate, in 2-year-old cows or cows greater than 2-years-old and in cows calved 40 d or less, or greater than 40 d. The use of 10 micrograms of the GnRH analogue, buserelin, 11 to 13 d after insemination, cannot be recommended as a method of improving reproductive performance in dairy herds.

Animals↗

PubMed1990

Efficacy of a cell extract from Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine.

We partially characterized a cell extract (CE) from Actinobacillus pleuropneumoniae serotype 1 and used the CE to test the efficacy of secreted proteins against disease. Secreted products from 4-h culture supernatants were precipitated with 20% polyethylene glycol. Analysis of the CE indicated the presence of protein, endotoxin, and carbohydrate. Hemolytic activity to bovine erythrocytes and cytotoxic activity to porcine mononuclear leukocytes was also demonstrated. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of the CE from a 4-h culture showed a major band at 110 kilodaltons (kDa), while a CE of a 26-h culture indicated the presence of a number of additional proteins, including the 110-kDa protein. The 110-kDa protein was also identified as a glycoprotein by periodic acid-Schiff and silver staining. A single band precipitated against convalescent-phase pig antiserum when the polyethylene glycol precipitate was used in an Ouchterlony plate. Vaccination with CE conferred greater protection against challenge with the homologous serotype than either a commercial bacterin or an outer membrane protein vaccine. Hemolysin-neutralizing titers were higher both pre- and postchallenge in the group vaccinated with the CE compared with in all other groups. We believe that this demonstrates the importance of secreted factors in protection against disease and suggests that the 110-kDa protein is an important immunogen.

Actinobacillus↗

PubMed1989

Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infection.

The in vivo administration of bovine recombinant interleukin-2 (rIL-2) was evaluated in calves vaccinated and then challenged with bovine herpesvirus-1 (BHV-1). In Experiment 1, 24 calves were allotted to four groups: control; bovine rIL-2; BHV-1 vaccine (modified-live); and bovine rIL-2 + BHV-1 vaccine. Serum neutralizing antibody titers to BHV-1 were increased sixfold, and virus shedding was fourfold less in calves vaccinated and treated with rIL-2 (25 micrograms/kg, intramuscularly) when compared to calves that received vaccine only. Treatment with rIL-2 induced lymphokine-activated killer activity that was eliminated by pretreating effector cells with complement and a monoclonal antibody (B26A) specific for the sheep red blood cell receptor. The rIL-2 treatment in BHV-1-vaccinated calves increased the calves' ability to withstand a BHV-1 challenge. However, during treatment with rIL-2, calves developed diarrhea and mild fever that abated after IL-2 treatment was stopped. A second experiment was then conducted to determine a dose of rIL-2 that would enhance immunity to BHV-1 without causing adverse side effects. Twenty-five calves were allotted to five groups that received injections of rIL-2 at 0.0, 25.0, 2.5, 0.25, or 0.025 micrograms kg-1 day-1 for 5 days. All calves received a modified-live BHV-1 vaccine. Calves treated with 25.0 micrograms kg-1 day-1 showed similar adverse side effects as in the first experiment but all other calves were normal. Compared to control calves, those treated with 25.0, 2.5, and 0.25 micrograms kg-1 day-1 of rIL-2 had higher (P less than 0.05) serum antibody titers to BHV-1 and following challenge lower (P less than 0.05) BHV-1 titers in nasal secretions; additionally, clinical disease as evidenced by nasal and ocular discharge was less severe (P less than 0.05). In vitro cytotoxic responses against BHV-1-infected bovine kidney cells were increased (P less than 0.05) in calves treated with rIL-2 in a dose dependent manner. These data suggest that bovine rIL-2 at 2.5 to 0.25 micrograms/kg may be an effective adjuvant to immunization.

Adjuvants, Immunologic↗

PubMed1989

Ribavirin inhibits proliferation of bovine respiratory syncytial virus in vitro.

Bovine respiratory syncytial virus (BRSV) is an important pathogen in bovine respiratory diseases in the United States. Proliferation of the disease can reach epidemic proportions with mortality reaching as high as 20%. In vitro work shown here suggests that the antiviral compound Ribavirin will be effective in the treatment of infected animals. Treatment at three dose levels with Ribavirin have shown significant inhibition of BRSV proliferation. Bovine turbinate cells were host cells for this study. Tissue culture specimens, infected and noninfected, were carried for 10 days. Presence of BRSV was verified with the use of monoclonal antibody. In addition, the infection with BRSV and consequential treatment with Ribavirin of calves demonstrated a noticeable reduction in viral symptom but no apparent systemic reaction to drug therapy.

Animals↗

PubMed1989

Activated porcine alveolar macrophages: are biological response modifiers the answer?

We report that 75% of conventionally housed 3- to 4-week-old swine already have detectable activated alveolar macrophages as measured by cytotoxicity of tumor cells. These macrophages can not be further activated by the biological response modifier N-acetylmuramyl-L-alanyl-Disoglutamine-2H2O (MDP). These macrophages lose cytotoxic activity when cultured for 24 h and this loss of activity can not be reversed by MDP. We suggest that MDP biological response modifier therapy of swine alveolar macrophages may not be a useful technique in preventing respiratory disease in swine.

Acetylmuramyl-Alanyl-Isoglutamine↗

PubMed1989

Evaluation of a regimen using a progesterone releasing intravaginal device (CIDR) and PMSG as a treatment for post partum anoestrus in dairy cattle.

Anoestrous dairy cows in seasonally calving herds in the Macalister Irrigation District of Gippsland, Victoria were treated at the start of the mating period with a progesterone releasing intravaginal device (CIDR). The CIDR was inserted for 7 days and 400 IU of PMSG was injected intramuscularly at removal. There was no clinically useful difference among cows receiving the CIDR, a placebo and untreated cows in the interval from treatment to either first oestrus or conception, the conception rate to first service or percent pregnant by the end of mating. Analyses of data from 2-year-old cows, older cattle, cows calved at least 45 days or cows calved at least 55 days and cows treated 3 weeks after the start of mating did not show improved reproductive performance following treatment with the CIDR.

Administration, Intravaginal↗

PubMed1989

Prognostic factors for recovery from coxo-femoral dislocation in cattle.

Details were recorded of 47 cases of coxo-femoral dislocation observed in cattle over 1 year. Treatment was successful in 20/47 (42.6%) cases using a method of closed reduction. Factors that most strongly influenced the prognosis were identified. The most useful single prognostic factor was whether the cow was able to stand before reduction. Other factors that also had a strong positive influence on the prognosis were: age less than 3y, bodyweight less than 400kg and duration of dislocation less than 12h. Nineteen unsuccessful cases were examined at the knackery. Four were found to have a fracture of the proximal femur. The coxo-femoral joint was carefully dissected in the other 15 cases and there was no evidence of hip dysplasia. A seasonal incidence of dislocations, which coincides with the calving and mating periods, was demonstrated during the survey and from practice records for the previous 3 years.

Age Factors↗

PubMed1989

Detection of bluetongue virus in bovine fetuses using the avidin-biotin complex immunoperoxidase method.

The avidin-biotin complex immunoperoxidase technique was adapted for use in detecting bluetongue virus (BTV) antigens in BTV serotype 11-infected bovine fetuses. Fetuses were infected with BTV serotype 11 at 120 days of gestation and then removed 20 days later by Cesarean section. Blood and tissue samples were collected from each animal and used for virus isolation in embryonated chicken eggs, the immunofluorescent antibody test, and the avidin-biotin complex test. The avidin-biotin complex method successfully identified BTV antigens in both fresh and autolyzed fetal brains. Thus, the avidin-biotin complex immunoperoxidase method has potential as a possible procedure for diagnosing bluetongue disease in aborted bovine fetuses.

Abortion, Veterinary↗

PubMed1989

Detection of bovine respiratory syncytial virus using a heterologous antigen-capture enzyme immunoassay.

Based on the marked antigenic similarities that exist between antigens of the human and bovine strains of respiratory syncytial virus (RSV), an enzyme immunoassay (EIA) designed to detect human RSV was used to detect bovine RSV. The commercial test kit (RSV EIA) consists of a solid phase (beads) coated with a capture antiserum prepared against the Long strain of human RSV. The RSV EIA test was compared with the method of inoculation of cell cultures and fluorescent antibody (FA) staining of lung tissue for the detection of bovine RSV. Using a cell culture-propagated stock of strain 375 of bovine RSV, the threshold of sensitivity of the EIA test for the cattle strain of RSV was determined to be less than or equal to 10(2.3) CCID50/ml. In addition, RSV EIA detected the bovine RSV in nasal samples obtained from 3 experimentally inoculated cattle. The RSV EIA exhibited a sensitivity of greater than or equal to 80% during the period that shedding of infectious virus took place. All of the bovine RSV FA-positive lung samples (n = 37) were positive by the RSV EIA. Twenty-six of the remaining 214 bovine RSV FA-negative lung samples were positive by the RSV EIA. The RSV EIA was also used to test 137 nasal swabs obtained from cases of bovine respiratory disease. Of these, 38 tested positive by RSV EIA. All samples that tested positive by EIA were confirmed by blocking assays using hyperimmune serum anti-bovine RSV and a pool of monoclonal antibodies specific for that virus.

Animals↗

PubMed1989

A blocking ELISA for the detection of specific antibodies to bovine respiratory syncytial virus.

A blocking enzyme-linked immunosorbent assay (ELISA) has been adapted to detect specific antibodies in bovine sera to respiratory syncytial virus using a horseradish peroxidase-labeled monoclonal antibody to the fusion protein of the virus. This assay plus an indirect blocking ELISA and indirect ELISA were used to detect antibodies to the bovine respiratory syncytial virus (BRSV) in 159 field-origin bovine sera. Results of these assays were compared with serum antibody titers measured by the serum neutralization (SN) test. Over a 56-day period, the mean neutralization titers and the mean delta absorbance values for the blocking ELISA, on the same sera, showed similar declines. However, the calculated correlation coefficients between mean SN titer and mean absorbance value for the blocking ELISA of the individual sera ranged from -0.2 to -0.5 depending on the source of sera. Similar values were obtained whether using crude or purified viral antigen in the assays. Corresponding calculated correlation coefficients were generally higher for the indirect blocking ELISA or indirect ELISA than for the blocking ELISA. The blocking ELISA was between 70 and 64% as sensitive as the serum neutralization test with a specificity of 100 or 90% using the crude and purified viral antigen, respectively. The indirect blocking ELISA and indirect ELISA had similar calculated sensitivities and specificities. The blocking ELISA was faster to run than either of the other ELISA's or the neutralization test. Further, nonspecific background absorbance was obviated because the blocking ELISA detects antibodies to 1 specific viral protein, the fusion protein. These studies suggest that the blocking ELISA should be useful as a serological test for BRSV antibodies.

Animals↗

PubMed1989

Evaluation of a biological response modifier: effects on starter pig performance.

The influence of a biological response modifier (FK-565) on weanling pig performance was evaluated. One hundred twenty-five weanling pigs (weaned at 21 +/- 3 d) averaging 6.3 kg were utilized in a 35-d growth trial. Dietary treatments included a basal diet (1.25% lysine, corn-soybean meal-dried whey), the basal plus .1, 1 or 10 ppm FK-565 and the control plus an antibacterial combination containing chlortetracycline, sulfamethazine and penicillin. Performance was recorded weekly, and on d 35 all pigs were bled for whole blood and serum chemistry profiles and then were euthanatized. Heart, liver, kidneys and spleen weights were recorded. Also, gross and histological examinations were made of these organs, as well as sections of lung, ileum, bone marrow, thymus and mesenteric lymph node. By d 14, pigs fed the antibacterial diet gained faster (P less than .06) than pigs fed the control and FK-565 diets. However, no differences (P less than .10) in feed intake at d 14 or efficiency of feed utilization at either d 14 or 35 were observed. For the overall 35-d trial, ADG was greater (P less than .01) for pigs consuming the antibacterial diet than for pigs consuming control and the FK-565 diets. Pigs consumed more of the antibacterial diet than of the other diets (P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Adjuvants, Immunologic↗

PubMed1989

Characterising the energy deposition events produced by trapped protons in low earth orbit.

Men and equipment in space vehicles in low earth orbit are exposed to a wide variety of radiations, but the majority of the dose is due to trapped protons, which have energies of the order of 100 MeV and are low LET particles. These high energy particles produce nuclear fragmentation with high LET secondaries that may be responsible for a significant fraction of dose equivalent. In order to understand better the biological effectiveness of this radiation environment, a portable tissue equivalent proportional counter spectrometer has been developed that automatically records the distribution of energy in a small tissue-like site as a function of time. This instrument weighs about 700 g and will be flown on a number of future space shuttle flights.

Cosmic Radiation↗